7月 2026
- 首頁
- Cobra Biologics
7月 2026Cobra Biologics的市場佔有率分析
charles river provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.
Cobra Biologics(包含公司地區)
查看更多網站流量與參與度資訊- cobrabio.com
Cobra Biologics截至 7月 2026 的總收入為 25M - 50M
Cobra Biologics 熱門網域產生的總收入
Cobra Biologics 熱門網域 3 年內的總收入
Cobra Biologics 熱門網域的總收入
Cobra Biologics的熱門網域總造訪量
了解Cobra Biologics市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
無可顯示數據
無可顯示數據
Cobra Biologics的熱門網域平均造訪時長
分析Cobra Biologics參與度指標。
過去 3 個月平均造訪時長
無可顯示數據
無可顯示數據
Cobra Biologics的熱門網域平均頁面瀏覽量
了解Cobra Biologics如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
無可顯示數據
無可顯示數據
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Cobra Biologics
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Charles River Chamber acquires Cobrabio.She said that Cobra Biologics, which was “a key part of the early scale for the vaccine manufacturing”, has been acquired by American pharmaceutical company Charles River.
11月 30, 2022閱讀更多
新聞Charles River Laboratories International, Inc. acquired Cobrabio on Jan 1st '21.The expansion follows Charles River’s acquisition of Keele, England-based Cobra Biologics, a plasmid DNA and viral vector cell and gene therapy contract development and manufacturing organisation (CDMO), in March 2021 and will see an additional 50 new positions created, from apprentices through to experienced scientists.
3月 7, 2022閱讀更多
新聞Charlesriver acquired Cobrabio on Mar 1st '21.The expansion follows Charles River’s acquisition of Keele-based Cobra Biologics, a pioneering plasmid DNA and viral vector cell and gene therapy contract development and manufacturing organisation (CDMO), in March 2021 and will see an additional 50 new positions created, from apprentices through to experienced scientists.
2月 24, 2022閱讀更多
查看所有Cobra Biologics信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
